What is DMAA's market cap?

$264.38M, based on the Nov 6 close of $10.89.

Does Drugs Made In America Acquisition pay a dividend?

No regular cash dividend has been paid in the last year.

How much of DMAA is sold short?

89.1K shares, 0.4% of float, as of Oct 15, 2026.

What sector is DMAA in?

Financials, in the Blank Checks industry.

NASDAQ · DMAAFinancialsBlank Checks

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

$10.890.00%

Close Nov 6, 2026 · split-adjusted

Nov 5, 2026$10.89▲ 5.52% in range

Nov 5, 2025Low $10.31 · High $10.89Nov 5, 2026

What changed · written from our data

As of Nov 6, 2026

Drugs Made In America Acquisition closed at $10.89 on Nov 6, unchanged — matching its highest close since Feb 25. Volume of 5.0K shares was 0.30× its 20-day average (below normal).

Split-adjusted performance: +0.4% over one month, +2.7% over six months.

Short interest was 89.1K shares at the Oct 15 settlement (0.4% of float, 8.3 days to cover).

Market cap$264.4M24.3M shares

Revenue · quarter$0.00—

Diluted EPS$0.06−14.3% YoY

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Feb 2510.31 – 10.890.0% from high

Volume5.0K0.30× 20-day avg

Volatility · 60d1.8%Annualised

Short % of float0.4%8.3 days to cover

Net cash-$329.7KCash $20.3K

Next earnings—Not scheduled

Split-adjusted performance

1W 0.0%1M +0.4%3M +1.7%6M +2.7%YTD +5.0%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Blank Checks

Percentile among 170 companies (100 = best)

6-month momentum95

Revenue growth—

Net margin—

Value (low P/E)—

Size42

Industry medians: 6-month return +1.8%, revenue growth −2.0%, net margin −70.6%, P/E 41.4×.

Short interest

Details →

Shares short89.1K−0.8% vs prior

Days to cover8.3Settled Oct 15

% of float0.4%

Short vol. 10d46.9%of daily volume

Closest peers by size in Blank Checks

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
DMAADrugs Made In America Acquisition	$10.89	0.00%	+2.7%	—	—	—	$264.4M
OACCOaktree Acquisition Corp. III Life Sciences	$10.70	−0.19%	+0.8%	—	—	—	$263.0M	Compare
CATLCatalyst Acquisition	$9.80	−0.19%	—	—	—	—	$266.1M	Compare
XTERXterax Corporation II	$9.78	+0.10%	—	—	—	—	$267.2M	Compare
CGCFCartesian Growth Corporation IV	$9.79	+0.20%	—	—	—	—	$269.2M	Compare
VNMEVendome Acquisition Corporation I	$10.35	+0.29%	—	—	—	—	$258.8M	Compare
DNMXDynamix Corporation III	$10.11	−0.10%	+1.3%	—	—	—	$271.3M	Compare
SCIISC II Acquisition	$10.20	0.00%	—	—	—	—	$254.0M	Compare
CEPOCantor Equity Partners I	$10.80	0.00%	+2.2%	—	—	—	$275.4M	Compare

News about Drugs Made In America Acquisition

All news →

No recent articles focused on Drugs Made In America Acquisition.

Quick answers

What does Drugs Made In America Acquisition do?: Drugs Made In America Acquisition Corp is a blank check company.
What is DMAA's market cap?: $264.38M, based on the Nov 6 close of $10.89.
Does Drugs Made In America Acquisition pay a dividend?: No regular cash dividend has been paid in the last year.
How much of DMAA is sold short?: 89.1K shares, 0.4% of float, as of Oct 15, 2026.
What sector is DMAA in?: Financials, in the Blank Checks industry.

About Drugs Made In America Acquisition

Drugs Made In America Acquisition Corp is a blank check company.

HQ: New York, NYListed Feb 25, 2025

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology